Blocknomi
Key Highlights AstraZeneca shares climb following successful DESTINY-Lung04 Phase 3 trial outcomes. Enhertu demonstrates superior progression-free survival versus standard first-line therapy. Trial results pave the way for Enhertu’s expansion into…
Related articles
-
Trump’s Oil Order Meets OPEC+ Supply Hike: Why California Gas Costs $5.49
BeInCrypto Published 02.08.2026 19:15
-
World Liberty Trust Clears First OCC Hurdle to Replace BitGo as USD1 Custodian
BlockchainReporter Published 15.08.2026 21:00
-
SEC Crypto Meeting Canceled as Token Exemption Vote Faces Delay
Blocknomi Published 13.08.2026 22:40
-
Ondo founder’s mother seeks CEO ouster in Delaware
Crypto.News Published 07.08.2026 05:18
-
Ireland’s New AML Strategy Brings ‘Enhanced Checks’ on Private Crypto Wallets
Decrypt Published 14.08.2026 12:38
-
Galaxy Digital lost $85M on crypto as its projected $80M in AI revenue must offset $3.5B AI investment
CryptoSlate Published 06.08.2026 21:05
-
Coldcard Wallet Attacks Enter Fourth Wave, Putting 449 BTC at Risk
CryptoPotato Published 03.08.2026 07:47
-
Investors poured $82 million into Canary’s XRP ETF, but falling prices erased double what they put in
CryptoSlate Published 10.08.2026 01:20